Company news
Intelligent Bio Solutions Inc. news in 2025
Intelligent Bio Solutions Inc.'s news releases, calls and decks from 2025, newest first.
Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
December 31, 2025
Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins
December 31, 2025
Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-Invasive Screening and Consumer Health Monitoring
December 18, 2025
Intelligent Bio Solutions Inc. Announces Reverse Stock Split
December 12, 2025
Intelligent Bio Solutions to Participate in Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference on December 2-3, 2025
November 20, 2025
Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue Growth
November 12, 2025
Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-Year
November 4, 2025
Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480
October 30, 2025
Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider
October 23, 2025
Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance
September 26, 2025
Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System
September 17, 2025
Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July
August 19, 2025
Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies
August 15, 2025
Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025
August 12, 2025
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum
August 7, 2025
Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch
August 6, 2025
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator
July 30, 2025
Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds
July 25, 2025
Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience
July 23, 2025
Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority
July 16, 2025
Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing
July 15, 2025
Intelligent Bio Solutions to Present PK Study Data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo
July 10, 2025
Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia
June 25, 2025
Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion
June 18, 2025
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Harry Simeonidis, President and CEO of Intelligent Bio Solutions Inc.
June 17, 2025
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing
June 11, 2025
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing
May 22, 2025
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
May 19, 2025
Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing
May 15, 2025
Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements
May 13, 2025
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion
May 6, 2025
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System
April 22, 2025
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System
March 31, 2025
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show
March 28, 2025
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra
March 27, 2025
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry
March 26, 2025
Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch
March 25, 2025
Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant
March 20, 2025
Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th
March 11, 2025
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common Stock
February 21, 2025
Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock
February 20, 2025
Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock
February 19, 2025
Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements
February 12, 2025
Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy
February 9, 2025
Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade
January 30, 2025
Intelligent Bio Solutions Partners with IVY Diagnostics to Expand in Europe’s $3.6 Billion Drug Screening Market and in Middle Eastern Regions
January 27, 2025
Decks in 2025
- Investor Presentation (December 2025)
Investor deck · 23 slides · Dec 2, 2025